This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Injury of nerves at hip and thigh level
ST19_INJURY_NERVES_HIP_THIGH_LEVEL
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
156 |
4. Check minimum number of eventsNone |
156 |
5. Include endpointsNone |
156 |
6. Filter based on genotype QC (FinnGen only) |
142 |
Control definitions (FinnGen only)
- Control exclude
- ST19_INJURI_HIP_THIGH
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- S7
- Name in latin
- Laesio nervorum regionis coxae/femoris
Similar endpoints
↥List of similar endpoints to
Injury of nerves at hip and thigh level
based on the number of shared cases.
Similar with more cases:
- Injuries to the hip and thigh
- Injury, poisoning and certain other consequences of external causes
- Any operation in hilmo
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 142 | 79 | 63 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | 59.09 | 55.79 | 63.22 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 145
- Matched controls
- 1450
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
S74.0
ICD-10 Finland
Injury of sciatic nerve at hip and thigh level
+∞
46.4
42
*
S74.1
ICD-10 Finland
Injury of femoral nerve at hip and thigh level
+∞
35.9
33
*
S74.9
ICD-10 Finland
Injury of unspecified nerve at hip and thigh level
+∞
30.3
28
*
S74.2
ICD-10 Finland
Injury of cutaneous sensory nerve at hip and thigh level
+∞
25.8
24
*
N03AX16
ATC
[U] pregabalin
5.6
23.8
72
217
X58
ICD-10 Finland
Exposure to other specified factors
6.1
22.8
53
126
N03AX12
ATC
[U] gabapentin; oral
4.8
17.7
55
164
NF1AA
NOMESCO Finland
Hip X-ray examination
6.5
17.5
33
63
S74.8
ICD-10 Finland
Injury of other nerves at hip and thigh level
+∞
17.0
16
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
4.2
16.4
73
282
NE1AA
NOMESCO Finland
Pelvis X-ray examination
6.7
16.3
29
52
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
5.3
15.1
36
85
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
4.9
14.0
37
95
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
5.3
13.7
32
74
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.4
12.8
39
112
N02AX02
ATC
tramadol; systemic, rectal
3.6
12.7
89
447
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.1
12.5
24
46
N02BF02
ATC
pregabalin; oral
5.1
10.5
24
54
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
11.3
10.4
19
19
N06AX21
ATC
duloxetine; oral
4.0
10.1
34
104
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
28.3
10.0
13
5
X59
ICD-10 Finland
Exposure to unspecified factor
3.3
9.7
47
183
S72.0
ICD-10 Finland
Fracture of neck of femur
106.7
9.5
10
*
B01AB05
ATC
enoxaparin; parenteral
3.0
9.5
67
323
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.0
9.4
72
362
N06AX16
ATC
venlafaxine; oral
3.5
9.3
39
138
ZXE10
NOMESCO Finland
More than one and less than three hours
2.9
9.1
72
367
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
20.2
9.1
13
7
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
3.7
9.1
33
106
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
11.8
9.0
16
15
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.5
8.9
36
124
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
10.0
8.8
17
19
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
12.7
8.8
15
13
S76.3
ICD-10 Finland
Injury of muscle and tendon of the posterior muscle group at thigh level
53.3
8.8
10
*
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
17.7
8.7
13
8
S70.0
ICD-10 Finland
Contusion of hip
21.6
8.6
12
6
T93.4
ICD-10 Finland
Sequelae of injury of nerve of lower limb
95.4
8.5
9
*
M54.4
ICD-10 Finland
Lumbago with sciatica
3.1
8.1
42
168
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.8
7.9
58
281
NF3AA
NOMESCO Finland
Femur X-ray examination
16.2
7.9
12
8
ZXD05
NOMESCO Finland
Urgent procedure
2.7
7.8
61
304
M79.6
ICD-10 Finland
Pain in limb
2.7
7.8
84
492
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
26.6
7.7
10
*
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
4.5
7.6
20
50
M16.1
ICD-10 Finland
Other primary coxarthrosis
3.5
7.6
29
96
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
8.0
7.4
16
22
S73.0
ICD-10 Finland
Dislocation of hip
+∞
7.3
7
*
S72.3
ICD-10 Finland
Fracture of shaft of femur
+∞
7.3
7
*
Y83.1
ICD-10 Finland
Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
17.7
6.8
10
6
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
13.1
6.7
11
9
ZXA00
NOMESCO Finland
Right side
2.6
6.6
50
242
L28
ICPC
Limited function/disability (L)
2.8
6.6
39
166
R4120
NOMESCO Finland
Occupational therapy
4.1
6.6
19
51
N03AX09
ATC
lamotrigine; oral
5.7
6.6
18
35
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.5
6.6
80
484
G57.2
ICD-10 Finland
Lesion of femoral nerve
72.9
6.5
7
*
Z3226
NOMESCO Finland
Physiotherapist
2.8
6.4
39
169
M17.1
ICD-10 Finland
Other primary gonarthrosis
2.7
6.3
43
197
S72.4
ICD-10 Finland
Fracture of lower end of femur
+∞
6.3
6
*
NFJ62
NOMESCO Finland
Internal fixation of fracture of other parts of femur with plate
+∞
6.3
6
*
ZXD35
NOMESCO Finland
Usual procedure
8.3
6.3
13
17
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.1
6.2
29
108
A28
ICPC
Limited function/disability NOS
2.9
6.2
34
139
S18
ICPC
Laceration/cut
2.4
6.2
83
520
WX212
NOMESCO Finland
Femoral plexus blockade
13.3
6.2
10
8
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
4.1
6.1
18
49
ZXE00
NOMESCO Finland
One hour or less
2.4
6.1
69
401
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.2
6.0
27
98
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
98
599
2.96
8.69
4.0
2.8
—
—
estimate
—
0
0
15
25
6.56
6.19
2.0
1.8
—
—
—
0
0
56
302
2.39
5.78
4.2
2.5
—
—
—
0
0
53
288
2.32
5.31
2.6
1.8
0.55
1.48
mg/l
2.82
42
232
43
247
2.05
3.57
6.0
3.4
23.61
223.46
ng/l
1.08
31
191
37
204
2.09
3.41
4.6
6.8
104.38
104.79
mmol/l
0.20
37
204
13
43
3.22
3.34
2.0
1.7
1.16
1.14
g/l
0.06
13
43
21
93
2.47
3.21
4.1
6.7
25.24
24.45
mmol/l
0.39
21
93
35
200
1.99
2.90
2.0
2.1
—
—
—
0
0
7
13
5.60
2.90
1.0
1.3
—
—
—
0
0
5
6
8.57
2.77
1.0
1.0
—
—
—
0
0
7
14
5.19
2.76
1.0
1.3
—
—
—
0
0
12
43
2.95
2.72
2.0
1.7
0.26
0.21
g/l
1.06
12
43
65
464
1.73
2.62
2.6
3.1
27.72
36.21
u/l
1.30
65
439
5
7
7.34
2.57
1.0
1.4
—
—
—
0
0
85
657
1.71
2.54
7.7
7.3
1.21
1.21
mmol/l
0.05
75
562
66
479
1.69
2.47
4.9
3.2
—
—
—
0
0
28
157
1.97
2.44
5.0
5.1
221.57
252.33
u/l
0.92
28
148
26
142
2.01
2.43
2.0
2.0
—
—
—
0
0
6
12
5.16
2.42
1.0
1.2
—
—
—
0
0
27
150
1.98
2.41
2.0
1.9
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
9
5.71
2.23
1.0
1.3
—
—
—
0
0
11
42
2.75
2.20
1.5
2.0
—
—
—
0
0
20
103
2.09
2.18
1.9
2.4
3.19
5.02
ug/l
0.57
20
91
9
31
3.03
2.11
1.0
1.3
—
43.40
—
0
5
135
1231
2.40
1.98
28.1
16.2
25.33
22.36
mg/l
0.46
121
1011
67
512
1.57
1.92
4.3
3.9
18.55
42.39
ng/l
2.27
50
368
89
726
1.58
1.92
7.3
7.3
9.85
11.39
umol/l
1.46
89
693
54
393
1.60
1.90
4.6
3.1
0.32
0.46
e6/l
0.43
41
288
23
132
1.88
1.87
2.0
2.8
0.24
0.22
g/l
0.50
23
122
46
323
1.62
1.87
2.6
2.2
3.15
2.88
mg/l
0.24
46
283
13
61
2.24
1.77
1.3
1.4
—
—
—
0
0
6
18
3.43
1.76
1.3
1.1
—
—
—
0
0
5
13
3.94
1.73
1.0
1.4
1.68
2.06
mmol/l
—
5
13
92
767
1.55
1.72
11.3
10.8
3.97
4.00
e9/l
0.04
78
666
8
31
2.67
1.68
1.3
1.1
—
—
—
0
0
10
42
2.48
1.65
1.4
2.4
—
—
—
0
0
23
139
1.78
1.60
2.1
4.1
5.99
5.51
kpa
1.03
23
134
7
26
2.78
1.60
3.4
2.1
7.97
8.21
pmol/l
—
7
26
51
380
1.53
1.58
5.2
3.9
0.04
0.00
estimate
0.48
24
152
7
27
2.67
1.53
1.0
1.3
—
—
—
0
0
7
27
2.67
1.53
1.0
1.3
—
—
—
0
0
20
118
1.81
1.51
2.0
3.2
4.91
4.43
kpa
0.48
20
113
9
39
2.39
1.46
1.1
1.3
—
2.88
—
0
13
9
41
2.27
1.40
1.7
1.6
—
—
—
0
0
46
346
1.48
1.34
2.5
3.2
330.50
340.70
umol/l
0.31
40
306
29
199
1.57
1.27
2.5
2.5
21.26
23.62
%
0.47
29
189
22
141
1.66
1.26
4.1
3.7
—
—
—
0
0
63
509
1.42
1.25
4.4
4.0
0.00
0.00
estimate
-0.00
17
132
53
415
1.44
1.24
2.7
3.0
644.46
1301.07
ng/l
1.94
45
339
17
102
1.76
1.22
5.4
7.9
0.52
0.64
%
0.53
17
102
5
19
2.69
1.22
13.6
5.6
13.58
11.34
mg/l
—
5
19
12
64
1.95
1.22
2.0
2.2
—
—
—
0
0
107
953
1.47
1.21
4.8
4.5
14.93
14.86
pmol/l
0.10
100
865
8
39
2.11
1.17
1.3
2.0
—
—
—
0
0
17
104
1.72
1.15
6.4
3.2
57.13
63.00
ml/min/173m2
—
8
48
37
277
1.45
1.09
4.6
4.0
1.02
1.02
kg/l
0.80
28
180
27
191
1.51
1.04
5.0
5.7
1.06
1.08
mmol/l
0.22
21
173
7
34
2.11
1.04
1.1
1.2
—
—
—
0
0
33
247
1.44
0.97
1.3
1.3
37.58
32.04
iu/ml
—
9
88
30
221
1.45
0.96
5.4
3.3
2.86
2.71
e6/l
0.06
16
109
136
1296
1.80
0.95
31.3
21.3
77.21
78.06
umol/l
0.15
136
1281
11
63
1.81
0.93
2.4
1.8
—
—
—
0
0
42
331
1.38
0.93
1.5
1.3
1.54
1.66
u/ml
—
10
97
17
111
1.60
0.92
1.6
1.4
—
—
—
0
0
10
56
1.84
0.90
1.7
2.1
—
—
—
0
0
16
104
1.61
0.89
5.7
7.8
1.24
1.17
%
0.19
16
104
15
98
1.59
0.82
1.5
1.6
—
—
—
0
0
112
1033
1.37
0.82
29.4
20.6
13.93
13.64
%
1.11
112
1025
14
91
1.60
0.78
1.1
1.3
507.96
528.32
u/ml
0.01
14
86
6
34
1.80
0.77
1.7
1.5
—
0.10
—
0
7
47
388
1.31
0.76
4.0
3.7
0.00
0.01
estimate
0.50
20
130
5
24
2.12
0.75
1.4
1.6
—
—
—
0
0
79
700
1.28
0.74
5.0
4.0
0.00
0.00
estimate
-0.00
24
149
5
25
2.03
0.73
1.0
1.0
—
—
—
0
0
77
682
1.28
0.72
5.1
4.0
0.00
0.00
estimate
-0.00
24
159
78
692
1.28
0.72
4.9
4.0
0.00
0.00
estimate
-0.00
22
161
5
26
1.96
0.71
1.4
1.7
—
—
—
0
0
7
42
1.70
0.69
2.3
1.4
—
—
—
0
0
28
220
1.34
0.63
1.2
1.4
33.28
11.09
u/ml
—
9
90
30
239
1.32
0.62
4.1
3.1
1.59
0.75
e6/l
1.22
17
127
137
1328
1.57
0.57
39.5
25.0
132.24
135.70
g/l
1.79
137
1315
137
1327
1.59
0.57
39.1
24.9
258.81
250.43
e9/l
0.68
137
1305
137
1327
1.59
0.57
39.7
25.2
39.58
40.57
%
1.44
137
1313
137
1327
1.59
0.57
39.0
24.8
91.97
91.23
fl
0.83
137
1315
19
143
1.38
0.56
3.7
2.0
341.63
381.10
nmol/l
0.36
19
136
121
1153
1.30
0.51
6.3
5.5
1.81
1.90
mu/l
0.40
114
1050
7
45
1.58
0.49
5.6
2.1
0.00
0.00
g/l
—
7
45
62
559
1.19
0.43
2.6
2.1
90.26
95.05
pmol/l
0.47
38
279
5
33
1.53
0.42
1.4
1.7
—
—
—
0
0
6
42
1.45
0.36
2.3
1.9
—
—
—
0
0
10
73
1.40
0.35
1.1
1.3
—
—
—
0
0
6
43
1.41
0.35
1.5
1.3
—
—
—
0
0
49
441
1.17
0.34
5.1
4.2
9.39
7.97
mg/mmol
0.13
31
292
6
46
1.32
0.33
1.3
1.7
—
—
—
0
0
6
46
1.32
0.33
1.0
1.2
—
—
—
0
0
7
54
1.31
0.31
1.0
1.1
—
—
—
0
0
7
54
1.31
0.31
1.0
1.1
—
—
—
0
0
10
78
1.30
0.25
3.7
3.6
4.42
4.44
pmol/l
—
10
70
5
41
1.23
0.22
1.4
1.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
25.90
—
0
10
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
6
48
1.26
0.20
1.3
1.7
—
—
—
0
0
0
14
0.00
0.20
0.0
4.9
—
34.19
—
0
14
121
1181
1.15
0.20
7.1
6.7
38.56
39.78
mmol/mol
1.04
121
1111
35
321
1.12
0.18
3.4
5.1
24.66
23.04
%
0.24
17
172
14
120
1.18
0.17
2.4
1.8
—
—
—
0
0
8
68
1.19
0.17
1.1
1.0
—
—
—
0
0
12
139
0.85
0.15
4.4
5.1
3.91
7.36
ug/l
—
7
112
15
134
1.13
0.11
2.3
2.0
—
—
—
0
0
5
44
1.14
0.10
1.6
2.8
—
—
—
0
0
5
48
1.04
0.09
1.0
1.2
—
—
—
0
0
26
244
1.08
0.08
1.9
1.6
—
—
—
0
0
17
158
1.09
0.06
1.2
1.8
1.41
1.43
%
0.07
17
133
118
1167
1.06
0.06
4.6
4.4
1.38
1.29
mmol/l
0.61
112
1067
123
1220
1.05
0.04
5.3
5.2
1.41
1.46
mmol/l
0.56
116
1125
53
540
0.97
0.03
2.0
2.1
1.45
1.39
mmol/l
0.17
44
459
15
142
1.06
0.02
4.0
7.7
—
—
—
0
0
122
1212
1.04
0.02
5.2
5.1
6.00
5.96
mmol/l
0.11
116
1112
122
1224
0.98
0.00
5.5
5.3
4.66
4.61
mmol/l
0.21
117
1137
125
1249
1.01
0.00
6.1
6.0
2.77
2.70
mmol/l
0.35
119
1158
75
752
0.99
0.00
3.5
3.2
—
—
—
0
0
56
558
1.01
0.00
3.3
2.6
76.12
78.11
nmol/l
0.17
50
501
18
177
1.02
0.00
1.6
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
10.26
—
0
6
0
6
0.00
0.00
0.0
5.8
—
207.17
—
0
6
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
4.3
—
55.88
—
0
8
0
7
0.00
-0.00
0.0
3.4
—
4.49
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
43.06
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
25
250
1.00
-0.00
2.8
3.4
1.36
0.85
ug/l
0.45
15
166
0
8
0.00
-0.00
0.0
3.6
—
16.44
—
0
8
0
8
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
0.19
—
0
5
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.7
—
55.00
—
0
7
0
7
0.00
-0.00
0.0
3.4
—
10.57
—
0
7
0
8
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
4.6
—
1.38
—
0
8
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_INJURY_NERVES_HIP_THIGH_LEVEL – Injury of nerves at hip and thigh level
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).